Cargando…

In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model

Bone loss resulting from degenerative diseases and trauma is a significant clinical burden which is likely to grow exponentially with the aging population. In a number of conditions where pre-formed materials are clinically inappropriate an injectable bone forming hydrogel could be beneficial. The d...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorpe, Abbey A., Freeman, Christine, Farthing, Paula, Callaghan, Jill, Hatton, Paul V., Brook, Ian M., Sammon, Chris, Le Maitre, Christine Lyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915072/
https://www.ncbi.nlm.nih.gov/pubmed/29719605
http://dx.doi.org/10.18632/oncotarget.24813
_version_ 1783316809282224128
author Thorpe, Abbey A.
Freeman, Christine
Farthing, Paula
Callaghan, Jill
Hatton, Paul V.
Brook, Ian M.
Sammon, Chris
Le Maitre, Christine Lyn
author_facet Thorpe, Abbey A.
Freeman, Christine
Farthing, Paula
Callaghan, Jill
Hatton, Paul V.
Brook, Ian M.
Sammon, Chris
Le Maitre, Christine Lyn
author_sort Thorpe, Abbey A.
collection PubMed
description Bone loss resulting from degenerative diseases and trauma is a significant clinical burden which is likely to grow exponentially with the aging population. In a number of conditions where pre-formed materials are clinically inappropriate an injectable bone forming hydrogel could be beneficial. The development of an injectable hydrogel to stimulate bone repair and regeneration would have broad clinical impact and economic benefit in a variety of orthopedic clinical applications. We have previously reported the development of a Laponite(®) crosslinked pNIPAM-co-DMAc (L-pNIPAM-co-DMAc) hydrogel delivery system, loaded with hydroxyapatite nanoparticles (HAPna), which was capable of inducing osteogenic differentiation of mesenchymal stem cells (MSCs) without the need for additional growth factors in vitro. However to enable progression towards clinical acceptability, biocompatibility and efficacy of the L-pNIPAM-co-DMAc hydrogel to induce bone repair in vivo must be determined. Biocompatibility was evaluated by subcutaneous implantation for 6 weeks in rats, and efficacy to augment bone repair was evaluated within a rat femur defect model for 4 weeks. No inflammatory reactions, organ toxicity or systemic toxicity were observed. In young male rats where hydrogel was injected, defect healing was less effective than sham operated controls when rat MSCs were incorporated. Enhanced bone healing was observed however, in aged exbreeder female rats where acellular hydrogel was injected, with increased deposition of collagen type I and Runx2. Integration of the hydrogel with surrounding bone was observed without the need for delivered MSCs; native cell infiltration was also seen and bone formation was observed within all hydrogel systems investigated. This hydrogel can be delivered directly into the target site, is biocompatible, promotes increased bone formation and facilitates migration of cells to promote integration with surrounding bone, for safe and efficacious bone repair.
format Online
Article
Text
id pubmed-5915072
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-59150722018-05-01 In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model Thorpe, Abbey A. Freeman, Christine Farthing, Paula Callaghan, Jill Hatton, Paul V. Brook, Ian M. Sammon, Chris Le Maitre, Christine Lyn Oncotarget Research Paper Bone loss resulting from degenerative diseases and trauma is a significant clinical burden which is likely to grow exponentially with the aging population. In a number of conditions where pre-formed materials are clinically inappropriate an injectable bone forming hydrogel could be beneficial. The development of an injectable hydrogel to stimulate bone repair and regeneration would have broad clinical impact and economic benefit in a variety of orthopedic clinical applications. We have previously reported the development of a Laponite(®) crosslinked pNIPAM-co-DMAc (L-pNIPAM-co-DMAc) hydrogel delivery system, loaded with hydroxyapatite nanoparticles (HAPna), which was capable of inducing osteogenic differentiation of mesenchymal stem cells (MSCs) without the need for additional growth factors in vitro. However to enable progression towards clinical acceptability, biocompatibility and efficacy of the L-pNIPAM-co-DMAc hydrogel to induce bone repair in vivo must be determined. Biocompatibility was evaluated by subcutaneous implantation for 6 weeks in rats, and efficacy to augment bone repair was evaluated within a rat femur defect model for 4 weeks. No inflammatory reactions, organ toxicity or systemic toxicity were observed. In young male rats where hydrogel was injected, defect healing was less effective than sham operated controls when rat MSCs were incorporated. Enhanced bone healing was observed however, in aged exbreeder female rats where acellular hydrogel was injected, with increased deposition of collagen type I and Runx2. Integration of the hydrogel with surrounding bone was observed without the need for delivered MSCs; native cell infiltration was also seen and bone formation was observed within all hydrogel systems investigated. This hydrogel can be delivered directly into the target site, is biocompatible, promotes increased bone formation and facilitates migration of cells to promote integration with surrounding bone, for safe and efficacious bone repair. Impact Journals LLC 2018-04-06 /pmc/articles/PMC5915072/ /pubmed/29719605 http://dx.doi.org/10.18632/oncotarget.24813 Text en Copyright: © 2018 Thorpe et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Thorpe, Abbey A.
Freeman, Christine
Farthing, Paula
Callaghan, Jill
Hatton, Paul V.
Brook, Ian M.
Sammon, Chris
Le Maitre, Christine Lyn
In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model
title In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model
title_full In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model
title_fullStr In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model
title_full_unstemmed In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model
title_short In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model
title_sort in vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915072/
https://www.ncbi.nlm.nih.gov/pubmed/29719605
http://dx.doi.org/10.18632/oncotarget.24813
work_keys_str_mv AT thorpeabbeya invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel
AT freemanchristine invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel
AT farthingpaula invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel
AT callaghanjill invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel
AT hattonpaulv invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel
AT brookianm invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel
AT sammonchris invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel
AT lemaitrechristinelyn invivosafetyandefficacytestingofathermallytriggeredinjectablehydrogelscaffoldforboneregenerationandaugmentationinaratmodel